tiprankstipranks
Advertisement
Advertisement
Camp4 Therapeutics initiated with a Buy at Chardan
PremiumThe FlyCamp4 Therapeutics initiated with a Buy at Chardan
2M ago
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
Premium
Company Announcements
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
3M ago
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
Premium
Ratings
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
3M ago
CAMP Earnings this Week: How Will it Perform?
PremiumPre-EarningsCAMP Earnings this Week: How Will it Perform?
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
PremiumRatingsCAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
8M ago
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
Premium
Company Announcements
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
8M ago
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
Premium
Ratings
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100